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Background: Computer-based decision support systems are a promising method for incorporating research
evidence into clinical practice. However, evidence is still scant on how such information technology solutions work
in primary healthcare when support is provided across many health problems. In Finland, we designed a trial where
a set of evidence-based, patient-specific reminders was introduced into the local Electronic Patient Record (EPR)
system. The aim was to measure the effects of such reminders on patient care. The hypothesis was that the total
number of triggered reminders would decrease in the intervention group compared with the control group,
indicating an improvement in patient care.
Methods: From July 2009 to October 2010 all the patients of one health center were randomized to an
intervention or a control group. The intervention consisted of patient-specific reminders concerning 59 different
health conditions triggered when the healthcare professional (HCP) opened and used the EPR. In the intervention
group, the triggered reminders were shown to the HCP; in the control group, the triggered reminders were not
shown. The primary outcome measure was the change in the number of reminders triggered over 12 months.
We developed a unique data gathering method, the Repeated Study Virtual Health Check (RSVHC), and used
Generalized Estimation Equations (GEE) for analysing the incidence rate ratio, which is a measure of the relative
difference in percentage change in the numbers of reminders triggered in the intervention group and the control
group.
Results: In total, 13,588 participants were randomized and included. Contrary to our expectation, the total number of
reminders triggered increased in both the intervention and the control groups. The primary outcome measure did not
show a significant difference between the groups. However, with the inclusion of patients followed up over only six
months, the total number of reminders increased significantly less in the intervention group than in the control group
when the confounding factors (age, gender, number of diagnoses and medications) were controlled for.
Conclusions: Computerized, tailored reminders in primary care did not decrease during the 12 months of follow-up
time after the introduction of a patient-specific decision support system.
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The treatment of patients is based on clinical expertise,
whose key elements are research evidence, clinical situa-
tions and circumstances, and patients’ preferences and
actions [1]. The evidence is translated into practical form,
for example, in clinical practice guidelines [2], whereas
active incorporation of these into everyday practice has only
recently become a recognized target for research [3,4].
These methods have previously been summarized and the
conclusion is that because there are no magic formulae
[5,6], tailoring the intervention is necessary [7].
One of the innovations in the incorporation of evi-
dence into practice is computer-based decision support
to bring relevant evidence to the attention of healthcare
professionals (HCPs) at the point of care [8]. Such auto-
matic systems combine medical evidence with patient-
specific data from the Electronic Patient Record (EPR),
which supports clinical decision making [9-11]. Accord-
ing to a Cochrane Review of 28 studies, computer
reminders achieved a median improvement in process
adherence of 4.2% [12]. Focused computer-generated
reminders and alerts work well in a variety of single con-
ditions [13-16] and in preventive care [17]. Decision sup-
port can in many settings improve the quality of care
and help to avoid mistakes in clinical work, thereby im-
proving patient safety [18,19]. There is still, however, scant
evidence on how such information technology solutions
work across many diseases or conditions in primary
healthcare where multi-professional teams [20,21] care
for patients with multiple health problems, both acute
and chronic [22,23].
In our study, a set of evidence-based patient-specific
reminders in the form of the computer-based decision sup-
port service EBMeDS (Evidence-Based Medicine electronic
Decision Support, www.ebmeds.org) was integrated into
the EPR system of one primary care organisation. The
EBMeDS service aims to aid treatment across several
conditions in actual clinical practice and should therefore
be usable in primary healthcare. Our study question was:
‘Do patient- and problem-specific automatic reminders
shown to HCPs during primary care consultations have
an effect on patient care?’ We hypothesized that the
total number of triggered reminders would decrease
in the intervention group, in contrast to the control
group, indicating a possible improvement in patient care.
The hypothesis was formulated on the basis of the idea
of a gold standard, by which a triggered reminder in-
dicates that the patient care is not evidence-based, and
no reminder indicates that the patient care is evidence-
based.
The study was reviewed and accepted by the Pirkanmaa
Hospital District (Tampere University Hospital) Ethics
Committee (ETL R08149) and registered at ClinicalTrials.
gov (www.clinicaltrials.gov: NCT00915304).Methods
Trial design
The setting was the primary healthcare center of Sipoo,
which was selected from regular users of the Mediatri
EPR system. The center comprises 48 HCPs: 15 physi-
cians, 24 nurses and 9 other HCPs (physiotherapists, ward
nurses, a psychologist), described in detail elsewhere [24].
The HCPs used the EPR system during outpatient consul-
tations as well as on an inpatient ward typical of Finnish
primary care.
We used a parallel randomized controlled trial design,
with patient identification (ID) numbers in the EPR
system as the unit of randomization. We made use of
the Finnish Personal Identity Code (PIC), by which each
individual can be specifically identified [25], to produce
anonymized study IDs based on the PICs. All patients
who were listed as undergoing occupational healthcare
were excluded for legal reasons (Figure 1).
The study started in July 2009 and ended in October
2010.
We developed a unique method for population-based
outcome data gathering from the EPR archive, the
Repeated Study Virtual Health Check (RSVHC). During
an RSVHC, the EPR archive sent to the EBMeDS service
structured patient data (diagnoses, medications, and la-
boratory results) on the base study population (request),
and the service generated all reminders triggered by
these data and returned them (answer). The RSVHC was
planned to be performed weekly at night. Actually, one to
five RSVHCs were performed per month. The requests
and answers of each RSVHC were stored automatically in
a log file located in the EPR server, to be exported to the
study register and analyzed at the end of the study period.
The reminders were written by the EBMeDS editorial
team using medical evidence embedded in the sets of
Duodecim guidelines and other sources, and linked with
evidence-based decision support (DS) rules [26]. In April
2009, the 107 available DS rules were piloted in Sipoo.
Subsequently, the chief medical officer of the health center
decided which of the DS rules should be implemented.
These totalled 96.
Here is an example of an implemented DS rule that
conforms to if–then logic: ‘Metformin is the first choice
oral hypoglycaemic agent in type 2 diabetes’ (DS rule 16).
The DS rule is implemented if the diagnosis in the
EPR is type 2 diabetes. First, the rule checks whether the
medication list on the EPR contains metformin. If it
does not, the rule then checks for the plasma/serum
creatinine value from the EPR laboratory results. If the
glomerular filtration rate (GFR) is in the normal range,
then reminder one, ‘Type 2 diabetes – start metformin’
is shown on the screen. If the GFR is <60 ml/min, then
reminder two, ‘Type 2 diabetes—start metformin, note
GFR’ is shown. If the GFR is missing or out of date, then
July 2009
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RANDOMIZATION
Data 
gathering 
method:
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1-5 times 
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No reminders 
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Figure 1 Study design. RSVHC is the Repeated Study Virtual Health Check where all decision support rules are run at once and the triggered
reminders at the time point are registered; see text for explanation. Both the intervention and control groups were accrued as new individuals
visited the health center (i.e. first contact date). Therefore, the starting and end points of follow-up are individual. Occupational healthcare was
excluded. (See text and Figure 3 for further explanation).
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and start metformin’ is shown [26].
See Additional file 1 for more examples of DS rules
and reminders targeting diabetes patients, a large patient
group in primary care. HCPs can easily check back-
ground information and evidence behind each reminder
by clicking the reminder and opening the references.
Participants
This was a register-based study using the EPR data
without any direct contact with patients.
The first step in the data collection comprised 52
RSVHCs carried out between July 2009 and October
2010 in the base population. At the end of the study, the
population was 17,541 (total number of patient IDs in
the study register). Data in the RSVHCs were structured
patient-specific information (diagnoses, medications,
laboratory results), and the triggered patient-specific
reminders at each time point were stored in the study
register.
In the second step, using the study ID, the earliest date
was defined when the patient’s EPR had been opened dur-
ing the study (start of individual follow-up). All EBMeDS
procedures (requests and answers) which actually took
place during the study were stored in monthly log files
on the EPR server. One log file (April 2010) was missed
because of technical problems. A baseline date was deter-
mined individually for each study patient as the date ofthe first opening of the EPR during the study period, and
the patient-specific follow-up started from this date.
The third step involved linking the information from
steps one and two. These final data comprised patient-
specific information from the individual baseline date to
all RSVHC points where the patient was followed up.
The swine flu epidemic, with the ensuing universal
vaccination procedures, occurred between September
2009 and February 2010. We excluded from the monthly
log files patients who received only the swine flu vaccin-
ation during a short visit (5 to 10 minutes) with a nurse.
According to the nurses [27], nothing else was checked,
including triggered reminders.
Intervention
The intervention consisted of the patient-specific re-
minders being shown to the HCP on opening and using
the EPR. A concrete example, the reminders for one dia-
betes patient, has been published previously [27]. Short
versions of the triggered reminders, for example, ‘Type 2
diabetes—time for nephropathy screening’, were shown
automatically on screen. The full version of the re-
minders could be seen when the HCP hovered the
cursor over the reminder, for example, ‘This patient has
type 2 diabetes and no screening for microalbuminuria
has been carried out during the last year. Annual screening
for microalbuminuria is recommended in type 2 diabetes’.
See Table 1 for examples of the reminders according to
Table 1 Examples of the EBMeDS reminders listed according to ICD-10 coding system
Decision
support ID
Decision support title Reminder
number
Reminder (short version)
Cardiovascular diseases (IX, Diseases of the circulatory system)
scr00457 Anticoagulants for atrial fibrillation 1 Atrial fibrillation—start warfarin?
2 Atrial fibrillation—consider warfarin?
scr00578 Follow-up of patients with hypertension 1 Hypertension—time to check blood pressure?
2 Elevated blood pressure in last measurement—time to check blood pressure?
Ear diseases (VIII, Diseases of the ear and mastoid process)
scr00424 Avoiding decongestants and
antihistamines in otitis media in children
1 Otitis media—avoid decongestants and antihistamines
Endocrine and metabolic diseases (IV, Endocrine, nutritional and metabolic diseases)
scr00665 An abnormal potassium result 1 Serum potassium is dangerously out of range (@1)!
2 Serum potassium is out of range (@1)
3 Serum potassium is slightly out of range (@1)
Genitourinary diseases (XIV Diseases of the genitourinary system)
scr00107 GFR below 55 ml/min 1 Decreased GFR—no diagnosis of renal failure
2 Decreased GFR and no recent creatinine test—order new creatinine test?
Haematological diseases (III, Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism)
scr00664 Low haemoglobin concentration in
adults and adolescents
1 Decreased haemoglobin concentration—start investigations?
Musculoskeletal diseases (XIII, Diseases of the musculoskeletal system and connective tissue)
scr00012 Prevention of osteoporosis in long-term
use of glucocorticoids
1 Long-term glucocorticoids—add calcium and vitamin D?
2 Long-term glucocorticoids—add a bisphosphonate?
Neoplastic diseases (II, Neoplasms)
scr00094 Follow-up of high PSA concentration 1 High PSA—time to repeat the test?
2 High PSA—time to repeat the test? Note 5-alpha reductase medication
Nervous system diseases (VI, Diseases of the nervous system)
scr00425 SSRIs not indicated for headaches 1 Headache—SSRIs are not recommended
Respiratory diseases (X, Diseases of the respiratory system)
scr00494 Inhaled corticosteroids instead of oral
steroids for chronic asthma
1 Asthma treated with oral steroids—start inhaled steroids?
2 Asthma treated with courses of oral steroids—start inhaled steroids?
(The decision support rule ID is included to assist interested readers to obtain more information at www.ebmeds.org).
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in Additional files 2, 3 and 4.
The control group was treated according to normal
practice, and the triggered patient-specific reminders
were not shown to the HCP on screen. Instead, these were
stored in the log files and exported to the study register.
Usual care and the evidence for that were available to
HCPs at all times during the trial, by active searching
of, e.g., guidelines.
There are four different EBMeDS decision support ser-
vice functions: reminders, guideline links, a clinical virtual
health check, and drug alerts (Table 2). Reminders and
drug alerts are triggered automatically, but the guideline
links and clinical virtual health check functions need active
querying. Here, we focused only on the automatic reminderfunction. The interface of the integrated systems (EPR and
EBMeDS) was designed by the EPR system vendor.
The number of reminders selected for the study was
154, based on 73 DS rules. After piloting, we had to ex-
clude 23 of the original 96 DS rules (not triggered, n =
10, or not calculable, n = 13). In practice, 14 additional
DS rules failed to function as planned (missing labora-
tory codes or unexpected changes in the EPR system
after updates). After excluding a further 38 reminders
based on these 14 DS rules, the analyzable final max-
imum number of different reminders was 116 (Figure 2).
Outcomes
The primary composite outcome measure was the change
in the numbers of all reminders triggered in the target
Table 2 The four EBMeDS decision support functions
available for the healthcare professional
Function Description
Reminders (See Table 1
and Additional file 2 for
more detail)
These are patient-specific and the short version
is shown automatically, the long version when
the cursor hovers over the reminder. These
are triggered on: opening of the patient
record; or recording a new diagnosis; or
prescribing new medication.
The focus of the present paper.
Guideline links These are shown in accordance with
the patient’s diagnosis list and ICD-10 codes.
Virtual health check
(VHC)
The healthcare professional can run a (clinical)
VHC on a selected group of patients.
Patient-specific reminders appear on the
screen, which can be used e.g., for planning
the following day’s consultations.
Drug alerts Reminders triggered on prescribing a
medication.
Evidence-based Decision S
EBMeDS service in April 2
Excluded DS rules n = 2
Medical ev
DS rules accepted for implem
Excluded DS rul
59 DS rules functioning as planned:
Producing 116 possible automatic remi
73 DS rules:
Producing 154 possible automatic remi
14 DS rules excluded b
reasons
Figure 2 The process of eliminating decision support rules from the a
decision support (DS) rules ending with the 59 rules that were used.
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secondary outcome measures, we explored the changes
also after three and six months of follow-up.
Sample size
We planned to include all of the Sipoo patients’ EPRs in
the study, and estimated that at least 50% of the popula-
tion would contact the health center during one year,
based on available data on visits to primary healthcare
centers in Finland, and local statistics [28]. This trans-
lated into an approximation of 10,500 participants in the
final study sample. The accumulation of the study par-
ticipants (n = 13,588) is shown in Figure 3.
Randomization
A single ratio procedure randomized the base popula-
tion of the health center at the beginning of the study to
an intervention and a control group of the same size
without any other criteria. The procedure was done once
per individual by a computer using a mathematical for-
mula based on the PIC of each patient in the EPR system,upport (DS) rules in the 
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Figure 3 Accumulation of study participants from July 2009 to October 2010.
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The forthcoming patients (for example, new inhabitants
of Sipoo) were randomized according to the same proced-
ure. The procedure was performed by a person outside
the study group who also retained the key of the formula
linking the PIC to the study ID number.
Blinding
The randomization was masked from the patients, the
HCPs, and the study group. However, when the HCP was
shown the patient-specific reminders on screen, he or she
knew that the patient belonged to the intervention group.
The study group first opened randomization after the data
collection period.
Statistical methods
Baseline characteristics of the intervention and control
group with ancillary analysis for triggered reminders were
performed using means and standard deviations or fre-
quencies and proportions (Table 3).
To investigate the effect of the intervention on patient
care, the outcome variable was the number of triggered
reminders in each RSVHC. Because the data were right-
skewed and the variance was greater than the mean, the
negative binomial model provided a better fit to the data
and accounted for over-dispersion better than a Poisson
regression model [29]. We used negative binomial re-
gression to model the number of triggered reminders at
12, 6, and 3 months follow-up times (Table 4, models 1
to 3). The negative binomial model included a variable
(group) to indicate the difference between groups at
baseline and a variable (time) to indicate the changes in
the number of triggered reminders over time. The differ-
ence in change in the number of triggered reminders
across the intervention between the two groups was tested
using an interaction term between group and time. Theexponent of the coefficient of the interaction term is the
incidence rate ratio (IRR), i.e., an estimate of the relative
difference in percentage change in the number of trig-
gered reminders in the intervention group, compared with
the control group. We also added to the models some po-
tential confounding variables, such as age, gender, number
of diagnoses, and number of medications.
To account for the within-participant correlation be-
tween repeated measures, we used Generalized Estima-
tion Equations (GEE) by using the STATA software
package (version 12.0 for Windows). Liang and Zeger
proposed the GEE approach in 1986 to deal with im-
practical probability distribution in handling correlated
responses [30]. We used different correlation structures
(exchangeable, first-order autoregressive and unstruc-
tured) to account for the correlation within each unit.
All models were evaluated in terms of how well they
fitted the data using the quasi-likelihood under the inde-
pendence model information criterion (QIC) for model
selection [31]. The model with the lowest QIC was se-
lected as the final model. Robust standard errors were
used for all GEE-fitted models. IRRs were presented with
95% confidence intervals (95% CI) and p-values. We
defined <0.05 risk of error as the significance p-value.
Results
In total, 17,541 potential participants were registered in
the study on the basis of the 52 RSVHCs. Of these, 13,588
individuals’ EPRs were accessed by the HCPs during the
study (Figure 4). The characteristics and descriptive statis-
tics of the analyzed participants in different models (age,
gender, number of diagnoses and triggered reminders at
baseline and at the end of the follow-up period, number
of medications at baseline, and number of participants
with no triggered reminder) are presented in Table 3. The
participants’ individual follow-up periods varied from 1
Table 3 Characteristics of the intervention and the control group in the three models
Model 1 with 12 months’
follow-up (indiv1_MO12)
Model 2 with 6 months’
follow-up (indiv1_MO6)
Model 3 with 3 months’
follow-up (indiv1_MO3)
Intervention Control Intervention Control Intervention Control
Number of patients
3,836 3,734 5,983 5,928 6,435 6,360
Age (mean, sd)
36.7 (27.8) 36.8 (27.6) 35.4 (26.0) 35.6 (25.8) 35.4 (25.7) 35.6 (25.6)
Gender (%)
Female 1,997 (52.1) 1,960 (52.5) 3,068 (51.3) 3,020 (51.0) 3,305 (51.4) 3,254 (51.2)
Male 1,839 (47.9) 1,773 (47.5) 2,915 (48.7) 2,907 (49.0) 3,130 (48.6) 3,105 (48.8)
Number of diagnoses at baseline (%)
0 1,253 (32.7) 1,220 (32.7) 2,335 (39.0) 2,325 (39.2) 2,576 (40.0) 2,568 (40.4)
1 913 (23.8) 862 (23.1) 1,385 (23.2) 1,344 (22.7) 1,467 (22.8) 1,433 (22.5)
2–3 995 (25.9) 985 (26.4) 1,402 (23.4) 1,392 (23.5) 1,490 (23.2) 1,460 (23.0)
4+ 675 (17.6) 667 (17.8) 861 (14.4) 867 (14.6) 902 (14.0) 899 (14.1)
Number of diagnoses at the end of follow-up period (%)
0 458 (11.9) 460 (12.3) 1,302 (21.8) 1,341 (22.6) 1,643 (25.5) 1,695 (26.7)
1 729 (19.0) 713 (19.1) 1,460 (24.4) 1,425 (24.0) 1,669 (25.9) 1,626 (25.6)
2–3 1,253 (32.7) 1,229 (32.9) 1,820 (30.4) 1,816 (30.6) 1,866 (29.0) 1,820 (28.6)
4+ 1,396 (36.4) 1,332 (35.7) 1,401 (23.4) 1,346 (22.7) 1,257 (19.5) 1,219 (19.2)
Number of medications at baseline (%)
0 1,877 (48.9) 1,809 (48.4) 3,464 (57.9) 3,388 (57.2) 3,797 (59.0) 3,702 (58.2)
1–5 1,363 (35.5) 1,322 (35.4) 1.877 (31.4) 1,870 (31.5) 1,977 (30.7) 1,976 (31.1)
6–9 368 (9.6) 372 (10.0) 403 (6.7) 425 (7.2) 413 (6.4) 434 (6.8)
10+ 228 (6.0) 231 (6.2) 239 (4.0) 245 (4.1) 248 (3.9) 248 (3.9)
Number of triggered reminders at baseline (mean, sd)
0.30 (0.75) 0.31 (0.76) 0.23 (0.65) 0.23 (0.66) 0.23 (0.65) 0.23 (0.67)
Number of triggered reminders at the end of follow-up period (mean, sd)
0.45 (0.95) 0.45 (0.93) 0.27 (0.72) 0.28 (0.73) 0.24 (0.68) 0.25 (0.68)
Number of participants with no triggered reminder (%)
2,733 (71.2) 2,670 (71.5) 4,834 (80.8) 4,781 (80.7) 5,354 (83.2) 5,286 (83.1)
1Indiv = individual.
Kortteisto et al. Implementation Science 2014, 9:15 Page 7 of 12
http://www.implementationscience.com/content/9/1/15day to 480 days, which was decisive for inclusion in or
exclusion from the GEE models’ analyses.
Three GEE models were made (Table 4). The primary
outcome after 12 months, model indiv_MO12, included
all participants with individual follow-up for 12 months
(n = 7,570). At baseline, there were no differences be-
tween the intervention and control groups. The inci-
dence rate for triggered reminders increased significantly
(p = 0.002) over the follow-up period, and the interven-
tion and control group behaved similarly. The result was
congruent with confounding variables, such as age, gen-
der, number of diagnoses, and number of medications
(adjusted model).
The GEE model indiv_MO6 included all participants
with at least six months of follow-up (n = 11,911). Atbaseline, the intervention and control groups did not dif-
fer. The incidence rate for triggered reminders increased
significantly (p <0.001) during the follow-up period. The
difference in development between the groups was not
significant (p = 0.066) in the unadjusted model, but in
the adjusted model there was a significant difference
(p = 0.044), indicating that the number of reminders
increased less in the intervention group than in the
control group.
The GEE model indiv_MO3 included all participants
with at least three months of follow-up (n = 12,795). At
baseline, the intervention and control groups did not dif-
fer. During the follow-up period, the incidence rate for
triggered reminders increased significantly (p <0.001).
The intervention effect was not significant, indicating
Table 4 Incidence rate ratios (IRR) of the number of triggered reminders by negative binomial regression models using
a generalized estimation equation
Unadjusted Adjustede
IRR (95% CI) SEd p-value IRR (95% CI) SEd p-value
Indiv_MO12a
Group 1.002 (0.895 – 1.121) 0.057 0.98 1.004 (0.903 – 1.116) 0.054 0.94
Time 1.014 (1.001 – 1.023) 0.005 0.002 1.017 (1.008 – 1.026) 0.005 <0.001
Time2 1.002 (1.001 – 1.003) 0.0003 <0.001 1.002 (1.001 – 1.003) 0.0003 <0.001
Group × Time 1.001 (0.995 – 1.008) 0.003 0.73 1.002 (0.995 – 1.009) 0.003 0.56
Indiv_MO6b
Group 1.011 (0.913 – 1.120) 0.053 0.84 1.008 (0.923 – 1.101) 0.045 0.86
Time 1.038 (1.030 – 1.046) 0.004 <0.001 1.044 (1.036 – 1.052) 0.004 <0.001
Group × Time 0.990 (0.980 – 1.001) 0.005 0.066 0.989 (0.978 – 0.9997) 0.005 0.044
Indiv_MO3c
Group 0.990 (0.895 – 1.094) 0.051 0.84 1.013 (0.926 – 1.108) 0.046 0.77
Time 1.036 (1.024 – 1.050) 0.007 <0.001 1.046 (1.031 – 1.062) 0.008 <0.001
Group × Time 0.998 (0.980 – 1.017) 0.009 0.86 0.996 (0.975 – 1.018) 0.011 0.74
aIndiv_MO12 for the study patients with 12 months’ individual follow-up using exchangeable working correlation structure.
bIndiv_MO6 for the study patients with six months’ individual follow-up using exchangeable working correlation structure.
cIndiv_MO3 for the study patients with three months’ individual follow-up using the auto-regressive (AR1) working correlation structure.
dSemi-Robust Huber/White sandwich estimated standard errors.
eAdjusted for age, gender, number of diagnoses and number of medications.
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groups. The result was congruent with confounding
variables in the adjusted model.
We did not detect any direct harm to the participants
from the intervention during the trial. A conceivable
harm to the HCPs originated from needless or incorrect
reminders based on missing laboratory codes or unex-
pected changes in the EPR system after updates.
Discussion
The two new data-gathering methods, the RSVHC and
the monthly log file, functioned as planned. More than
70% of participants did not trigger reminders (Table 3),
probably because most reminders were for chronic con-
ditions and the proportion of elderly people is relatively
small in the Sipoo community. Contrary to our expecta-
tions, the difference in the number of reminders after
12 months of follow-up (primary outcome measure) be-
tween the intervention and control group was not signifi-
cant (Table 4), and the pattern was similar: increasing
numbers of reminders in the intervention and the control
group. We used the robust RCT method [32,33], and
the most likely explanation for the results is that the
recording of diagnostic codes improved markedly during
the trial (Table 3). However, at six months individual
follow-up time, the increase in the total number of re-
minders was significantly less in the intervention group
than in the control group, when controlling for the con-
founding factors, such as age, gender, number of diagno-
ses, and medications.Limitations
There are a number of possible explanations for the
results. First, the setting was one health center with 15
physicians making clinical decisions on diagnosis, medi-
cation, and laboratory tests. Because each physician took
care of patients in the intervention group as well as in
the control group, contamination was possible in so far
as the physicians could have learned to treat the control
group patients according to the reminders for the inter-
vention group patients. This possible learning effect can
be presumed, decreasing the trial effect. Therefore, the
present results are a conservative estimate, and in future
trials, a cluster randomization of several study sites or a
randomization of HCPs would be preferable.
Second, the set of study reminders was chosen by the
study group and may have addressed the HCPs’ needs
insufficiently. Tailoring the guidance to HCPs’ needs has
been indicated as a key issue for successful implementa-
tion [5,7]. Local HCPs, not only the Chief Medical Officer,
may have to be involved for an adequate understanding
of their needs as the starting point for developing and
implementing reminders, as had been indicated previously
[34]. Further, competence-based individual tailoring could
be helpful.
Some of the most common and important reminders,
including those warning of high LDL cholesterol, had to
be excluded from the analysis because the codes for la-
boratory tests had changed over time (which the research
group was not aware of), and only the old codes were
interpreted by the rules, resulting in false reminders based
Base population 19,537
Followed for 3 months                                                       
6,435
Followed for 3 months 
6,360
Excluded 3,953 (patient record 
not accessed during the study)
Randomized to control group
6,758
Randomized to intervention group
6,830
Randomized 17,541
Excluded 1,996 (patients who were  
listed in occupational healthcare)
Followed for 6 months
5,983
Followed for 6 months 
5,928
Followed for 12 months 
3,836
Followed for 12 months 
3,836
Figure 4 Flow chart of study participants. Follow-up time is individual. (Primary outcome measure shown in bold text).
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have resulted in mistrust of the reminders among the
HCPs, and poor compliance with all reminders.
Many patients were seen by nurses rather than physi-
cians, but the actions suggested by the reminders (like
ordering tests or medications) could only be taken by
physicians. The nurses may not always have consulted
physicians after they saw the reminders, resulting in no
action.
According to a meta-regression of 162 randomized tri-
als [35], the odds of success of computer-based decision
support are greater for systems that require HCPs to
provide reasons when overriding advice than for sys-
tems that do not. The odds of success are also better for
systems that provide advice concurrently to patients and
HCPs. The intervention system possessed neither of these
features.
There was a delay in implementing the EBMeDS
service due to technical problems. This necessitated retrain-
ing the HCPs, which for practical reasons was delayed
and took place in February 2010, eight months after the
introduction of the service [24]. This delay from theintroduction of the service to the training of the HCPs in
its use may partly explain the results.
Generalizability
The reliable performance of the data-gathering methods
gives confidence that they can be applied successfully in
future studies and combined with a more extensive use
of decision support, for example the monitoring and
auditing care of such large patient groups as those with
type 2 diabetes.
We managed to randomize all patients of the health
center as planned to two comparable study groups, indi-
cating a high validity of the results [36-38]. However, the
results may not be generalizable to other primary care
environments, where the EBMeDS service could be
more vigorously implemented. Another set of physicians
in another health center could use the reminders much
more or much less than the present 15 physicians, and
therefore the results could be totally different. Also, the
integration of the Mediatri EPR and the EBMeDS service
was unique. That reminders were triggered by only below
a third of the participants may be related to recording
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EPR. Further exploration is warranted.
Interpretation
The EBMeDS service, developed using the best available
evidence [9,10], aimed to offer recommendations to HCPs’
workflow across several conditions in primary care prac-
tice. During the trial, patient-specific reminders were trig-
gered systematically but had only limited effects on patient
care (our secondary outcome measure after six months’
individual follow-up time). Our results reaffirm previous
evidence [39-41] that implementation of computer-based
decision support is problematic. HCPs seem to accept the
service in principle [27,42], but in practice they may neg-
lect using the reminders for many practical reasons.
The intervention itself is complex, as reminders have
different purposes in accordance with decision support
rules (Table 1 and Additional files). Some provide advice
on diagnosis or medication or laboratory test decisions,
for example ‘Atrial fibrillation—start warfarin?’ (DS rule
457), and some are reminders to follow patient mea-
sures, for example ‘Hypertension—time to check blood
pressure?’ (DS rule 578). The expected time interval be-
tween consultations and changes in the patient record
differs across the reminders: some changes take place
quickly, even in one visit, for example, as the HCP re-
cords a new diagnosis or prescribes medication. By con-
trast, some changes need more time, at least until the
next visit or laboratory test. In the latter case, the time
interval between the triggering of the reminder and the
measurement of the outcome was too long for reminders
to show differences between the intervention and control
groups. Groups of reminders and individual reminders
should also be evaluated separately, probably after careful
tailoring of the time to outcome, in order to determine
the types of reminder that have an effect and when this
should be measured.
Environmental issues included functional changes in
the health center, such as turnover of staff, and the coin-
cidence of the swine flu epidemic with the trial, which
could have influenced the study. Moreover, the physi-
cians decided that ICD-10 diagnosis classification would
be used systematically from spring 2009. The use of the
classification was made a mandatory function for record-
ing patient data in each encounter. This might be a key
reason for changes in data entry during the trial. However,
in a randomized design both groups would have been
affected similarly. The reason for a patient visit may not
have had any bearing on the triggered reminders, resulting
in HCPs ignoring them. In fact, our feasibility study [27]
indicates that missing or outdated patient data on, for
example, medication, resulted in needless or wrong re-
minders. These had to be checked in the EPR, which took
time.We can speculate on at least three specific issues. First,
our hypothesis was based on an optimistic estimation of
the potential consequences of triggered reminders. We
assumed that if HCPs received patient-specific reminders
they would act on them, and that this automatically would
decrease the number of future reminders. We did not
recognize that other factors in patient care—above all,
changes in patient data recording—could have an opposite
effect: for example, recording a new diagnosis or medica-
tion would trigger new reminders instead of decreasing
the number of reminders triggered. This confirms previ-
ous findings [43,44].
Second, our choice of the primary outcome measure
and its timing was based only on our understanding,
without any actual evidence. Despite extensive research
during the planning of the trial, we could not find a study
to help us with this. Choosing the primary outcome mea-
sures is not easy [36].
Third, the analysis consisted of three models
(Indiv_MO12, Indiv_MO6, Indiv_MO3) based on the
different follow-up periods of the participants. In
order to be followed up for 12 months and be included
in the measurement of the primary outcome, a patient
had to have a first contact by the end of October 2009.
The starting date could be as late as April 2010 for inclu-
sion in the six-month follow-up period and July for inclu-
sion in the three-month period. Most notably, the groups
of individuals with 3, 6, or 12 months’ follow-up differed
in the numbers of diagnoses and medications at baseline
(Table 3). The higher numbers of diagnoses, medications
and triggered reminders in the 12-month group indicate
more chronically ill patients in this group than in the
other groups. The effects of the marked improvement in
diagnosis coding during the study are difficult to assess,
because the influence of reminders triggered for the inter-
vention group may differ from that in the control group.
Some of the reminders indicated to the HCP that diagno-
ses had not been coded. This may have resulted in more
comprehensive coding of some diagnoses in the interven-
tion group, which further may have resulted in more trig-
gered reminders than in the control group, because many
reminders could be triggered only if a specific diagnosis
was present. Adjusting for the number of all diagnoses
cannot fully remove this confounding factor.
Conclusions
We did not find an intervention effect of the reminders
on the primary outcome measure. However, a positive
effect was seen in the secondary measure over a six-
month follow-up period. This trial has to be considered
a pilot, identifying key factors to be taken account when
implementing and evaluating EBMeDS services or simi-
lar systems in the future. Patient information in the EPR
system has to be accurately recorded for the reminders
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integrated system should be confirmed before the trial
starts.
Presently, the integration of EBMeDS with any EPR
system includes a thorough and systematic check of, for
example, all existing laboratory code values. In inte-
grated systems, all technical changes such as routine up-
dating of the EPR system can influence the functioning
of the decision support system.Additional files
Additional file 1: Examples of implemented decision support rules
for diabetes and the reminders that may be triggered depending
on the patient [26].
Additional file 2: All analysed reminders [26]. The decision support
rule ID is included to assist interested readers to obtain more information
at www.ebmeds.org.
Additional file 3: Reminders that were excluded after local piloting
[26]. The decision support rule ID is included to assist interested readers
to obtain more information at www.ebmeds.org.
Additional file 4: Decision support rules that were excluded from
the analyses for technical and other reasons [26]. The decision
support rule ID is included to assist interested readers to obtain more
information at www.ebmeds.org.Competing interests
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